LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR ‐16‐5p/ ACSL4 axis to alleviate diabetic nephropathy
Journal of Diabetes Investigation · 2023-09 · 14 (9) · 1056-1069
DOI: 10.1111/jdi.14036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 14.06.2023. Verfasst von Xiangdong Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Ferroptosis, Hyperglycemia, RNA, Long Noncoding. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, The Engineering Research Center of Kidney Disease in Jiangxi Province.
Abstract (Originalsprache)
Background
Hyperglycemia accelerates the development of diabetic nephropathy (DN) by inducing renal tubular injury. Nevertheless, the mechanism has not been elaborated fully. Here, the pathogenesis of DN was investigated to seek novel treatment strategies.
Methods
A model of diabetic nephropathy was established in vivo , the levels of blood glucose, urine albumin creatinine ratio (ACR), creatinine, blood urea nitrogen (BUN), malondialdehyde (MDA), glutathione (GSH), and iron were measured. The expression levels were detected by qRT‐PCR and Western blotting. H&E, Masson, and PAS staining were used to assess kidney tissue injury. The mitochondria morphology was observed by transmission electron microscopy (TEM). The molecular interaction was analyzed using a dual luciferase reporter assay.
Results
SNHG1 and ACSL4 were increased in kidney tissues of DN mice, but miR‐16‐5p was decreased. Ferrostatin‐1 treatment or SNHG1 knockdown inhibited ferroptosis in high glucose (HG)‐treated HK‐2 cells and in db/db mice. Subsequently, miR‐16‐5p was confirmed to be a target for SNHG1, and directly targeted to ACSL4. Overexpression of ACSL4 greatly reversed the protective roles of SNHG1 knockdown in HG‐induced ferroptosis of HK‐2 cells.
Conclusions
SNHG1 knockdown inhibited ferroptosis via the miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy, which provided some new insights for the novel treatment of diabetic nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
- Emergency Department, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
ORCID-Profile: Ben Ke
Förderung
- National Natural Science Foundation of China
- The Engineering Research Center of Kidney Disease in Jiangxi Province
Zitieren
APA
Fang, X., Song, J., Chen, Y., Zhu, S., Tu, W., Ke, B., & Wu, L. (2023). LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR ‐16‐5p/ ACSL4 axis to alleviate diabetic nephropathy. Journal of Diabetes Investigation, 14(9), 1056-1069. https://doi.org/10.1111/jdi.14036
Vancouver
Fang X, Song J, Chen Y, Zhu S, Tu W, Ke B, et al. LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR ‐16‐5p/ ACSL4 axis to alleviate diabetic nephropathy. Journal of Diabetes Investigation. 2023;14(9):1056-1069. doi:10.1111/jdi.14036
BibTeX
@article{Fang2023,
author = {Fang, Xiangdong and Song, Jianling and Chen, Yanxia and Zhu, Shuying and Tu, Weiping and Ke, Ben and Wu, Lidong},
title = {LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR ‐16‐5p/ ACSL4 axis to alleviate diabetic nephropathy},
journal = {Journal of Diabetes Investigation},
year = {2023},
volume = {14},
number = {9},
pages = {1056--1069},
doi = {10.1111/jdi.14036}
}
EUVIMED